Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Efficacy and Safety of FIAsp Compared to Insulin Aspart Both in Combination With Insulin Detemir in Adults With Type 1 Diabetes

ClinicalTrials.gov ID: NCT01831765

Public ClinicalTrials.gov record NCT01831765. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 10, 2026, 4:33 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This trial is conducted in Europe and the United States of America (USA). The aim of the trial is to investigate efficacy and safety of FIAsp (faster-acting insulin aspart) compared to insulin aspart, both in combination with insulin detemir in adults with type 1 diabetes. This trial consists of two periods: a 26 week treatment period followed by a 26 week additional treatment period.

Study identification

NCT ID
NCT01831765
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
1,290 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 25, 2013
Primary completion
May 11, 2015
Completion
Jun 10, 2015
Last update posted
Jun 11, 2019

2013 – 2015

United States locations

U.S. sites
116
U.S. states
35
U.S. cities
90
Facility City State ZIP Site status
Novo Nordisk Investigational Site Mobile Alabama 36608
Novo Nordisk Investigational Site Tucson Arizona 85714
Novo Nordisk Investigational Site Tucson Arizona 85724
Novo Nordisk Investigational Site Anaheim California 92801
Novo Nordisk Investigational Site Concord California 94520
Novo Nordisk Investigational Site Escondido California 92025
Novo Nordisk Investigational Site Fresno California 93720
Novo Nordisk Investigational Site Fullerton California 92835
Novo Nordisk Investigational Site Inglewood California 90301
Novo Nordisk Investigational Site La Jolla California 92037
Novo Nordisk Investigational Site La Mesa California 91942
Novo Nordisk Investigational Site Long Beach California 90807
Novo Nordisk Investigational Site North Hollywood California 91606
Novo Nordisk Investigational Site Northridge California 91324
Novo Nordisk Investigational Site Poway California 92064
Novo Nordisk Investigational Site San Diego California 92037
Novo Nordisk Investigational Site Santa Barbara California 93105-4321
Novo Nordisk Investigational Site Santa Barbara California 93105
Novo Nordisk Investigational Site Ventura California 93003-2824
Novo Nordisk Investigational Site Ventura California 93003
Novo Nordisk Investigational Site Walnut Creek California 94598
Novo Nordisk Investigational Site Denver Colorado 80209
Novo Nordisk Investigational Site Newark Delaware 19713
Novo Nordisk Investigational Site Boca Raton Florida 33433
Novo Nordisk Investigational Site Coral Gables Florida 33134
Novo Nordisk Investigational Site Fleming Island Florida 32203
Novo Nordisk Investigational Site Fort Lauderdale Florida 33308
Novo Nordisk Investigational Site Fort Lauderdale Florida 33312
Novo Nordisk Investigational Site Jacksonville Florida 32204
Novo Nordisk Investigational Site Miami Florida 33015
Novo Nordisk Investigational Site Miami Florida 33136
Novo Nordisk Investigational Site Miami Florida 33156
Novo Nordisk Investigational Site Miami Florida 33173
Novo Nordisk Investigational Site Miami Florida 33174
Novo Nordisk Investigational Site Sanford Florida 32771
Novo Nordisk Investigational Site Tampa Florida 33614
Novo Nordisk Investigational Site Atlanta Georgia 30318
Novo Nordisk Investigational Site Atlanta Georgia 30339
Novo Nordisk Investigational Site Dunwoody Georgia 30338
Novo Nordisk Investigational Site Lawrenceville Georgia 30046
Novo Nordisk Investigational Site Roswell Georgia 30076
Novo Nordisk Investigational Site Honolulu Hawaii 96814
Novo Nordisk Investigational Site Idaho Falls Idaho 83404-7596
Novo Nordisk Investigational Site Nampa Idaho 83686-6011
Novo Nordisk Investigational Site Chicago Illinois 60064
Novo Nordisk Investigational Site Chicago Illinois 60607
Novo Nordisk Investigational Site Crystal Lake Illinois 60012
Novo Nordisk Investigational Site Springfield Illinois 62711
Novo Nordisk Investigational Site Muncie Indiana 47304
Novo Nordisk Investigational Site Lenexa Kansas 66219
Novo Nordisk Investigational Site Topeka Kansas 66606
Novo Nordisk Investigational Site Lexington Kentucky 40502
Novo Nordisk Investigational Site Lexington Kentucky 40503
Novo Nordisk Investigational Site Portland Maine 04101
Novo Nordisk Investigational Site Baltimore Maryland 21204
Novo Nordisk Investigational Site Baltimore Maryland 21287
Novo Nordisk Investigational Site Hyattsville Maryland 20782
Novo Nordisk Investigational Site Rockville Maryland 20852
Novo Nordisk Investigational Site Waltham Massachusetts 02453
Novo Nordisk Investigational Site Worcester Massachusetts 01655
Novo Nordisk Investigational Site Kalamazoo Michigan 49048
Novo Nordisk Investigational Site Eagan Minnesota 55123
Novo Nordisk Investigational Site Minneapolis Minnesota 55416
Novo Nordisk Investigational Site Kansas City Missouri 64106
Novo Nordisk Investigational Site Springfield Missouri 65807
Novo Nordisk Investigational Site Butte Montana 59701
Novo Nordisk Investigational Site Omaha Nebraska 68114
Novo Nordisk Investigational Site Henderson Nevada 89052-2649
Novo Nordisk Investigational Site Las Vegas Nevada 89128
Novo Nordisk Investigational Site Las Vegas Nevada 89148
Novo Nordisk Investigational Site Nashua New Hampshire 03063
Novo Nordisk Investigational Site Hoboken New Jersey 07030
Novo Nordisk Investigational Site Jersey City New Jersey 07306
Novo Nordisk Investigational Site Lawrenceville New Jersey 08648
Novo Nordisk Investigational Site Albuquerque New Mexico 87106
Novo Nordisk Investigational Site Albuquerque New Mexico 87109-2134
Novo Nordisk Investigational Site Albuquerque New Mexico 87131
Novo Nordisk Investigational Site Albany New York 12206
Novo Nordisk Investigational Site New York New York 10029
Novo Nordisk Investigational Site Rochester New York 14607
Novo Nordisk Investigational Site Smithtown New York 11787
Novo Nordisk Investigational Site Staten Island New York 10301-3901
Novo Nordisk Investigational Site Staten Island New York 10301
Novo Nordisk Investigational Site Chapel Hill North Carolina 27517
Novo Nordisk Investigational Site Greenville North Carolina 27834
Novo Nordisk Investigational Site Morehead City North Carolina 28557
Novo Nordisk Investigational Site Columbus Ohio 43201
Novo Nordisk Investigational Site Mentor Ohio 44060
Novo Nordisk Investigational Site Portland Oregon 97210
Novo Nordisk Investigational Site Portland Oregon 97239
Novo Nordisk Investigational Site Jenkintown Pennsylvania 19046-3638
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19140-5103
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19140
Novo Nordisk Investigational Site Greenville South Carolina 29605-4254
Novo Nordisk Investigational Site Chattanooga Tennessee 37411
Novo Nordisk Investigational Site Amarillo Texas 79106
Novo Nordisk Investigational Site Austin Texas 78731
Novo Nordisk Investigational Site Beaumont Texas 77701
Novo Nordisk Investigational Site Dallas Texas 75230
Novo Nordisk Investigational Site Dallas Texas 75231
Novo Nordisk Investigational Site Dallas Texas 75246
Novo Nordisk Investigational Site Dallas Texas 75390-9302
Novo Nordisk Investigational Site Houston Texas 77079
Novo Nordisk Investigational Site Houston Texas 77099
Novo Nordisk Investigational Site Lubbock Texas 79423
Novo Nordisk Investigational Site Plano Texas 75093
Novo Nordisk Investigational Site Round Rock Texas 78681
Novo Nordisk Investigational Site Sugar Land Texas 77479
Novo Nordisk Investigational Site Magna Utah 84044
Novo Nordisk Investigational Site Olympia Washington 98502
Novo Nordisk Investigational Site Renton Washington 98057
Novo Nordisk Investigational Site Spokane Washington 99201
Novo Nordisk Investigational Site Spokane Washington 99202-1334
Novo Nordisk Investigational Site Spokane Washington 99202-3649
Novo Nordisk Investigational Site Spokane Washington 99202
Novo Nordisk Investigational Site Spokane Washington 99208

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 75 non-U.S. sites.

Recently updated Diabetes trials

Other public records listing Diabetes. Sorted by last update posted; newest first. Not a recommendation.

All Diabetes trials →

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01831765, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 11, 2019 · Synced Sep 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01831765 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →